https://www.selleckchem.com/pr....oducts/SB-203580.htm
In conclusion, omega-3 modulates endocannabinoid tone, which subsequently attenuates inflammation and cardiometabolic risk factors. However, further randomized clinical trials are needed before any recommendations are made to target the ECS using omega-3 as an alternative therapy to drugs for cardiometabolic disease improvement. PURPOSE describing long-term survival and toxicity outcomes of a multicenter randomized phase II trial comparing radiotherapy (RT) plus cisplatin (CDDP) or cetuximab (CTX) as first line treatment in locally ad
Like
Comment
Share
